Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old.
Feras KhalilSiak Leng ChoiEstelle WatsonThomas M TzschentkeClaudia LefeberMariëlle EerdekensJan FreijerPublished in: Journal of pain research (2020)
The development of tapentadol is one of the first examples following a systematic approach for analgesic drug development for children. Our analysis enabled a full characterization and robust understanding of tapentadol PK in children from birth to <18 years, including preterm infants, and showed the importance of evaluating the sensitivity of the inferences of the PK parameters to the selected scaling approach.